Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient-Reference-Cited by-同舟云学术

Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient

Published:2018-07-19 Issue:10 Volume:48 Page:1764-1767
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Horio Yuko¹,Takamatsu Koutaro²,Tamanoi Daisuke¹,Sato Ryo¹,Saruwatari Koichi¹,Ikeda Tokunori²³,Nakane Shunya²⁴,Nakajima Makoto²,Saeki Sho¹,Ichiyasu Hidenori¹,Fujii Kazuhiko¹,Tomita Yusuke¹^ORCID

Affiliation:

1. Department of Respiratory Medicine, Graduate School of Medical Sciences; Kumamoto University; Kumamoto Japan

2. Department of Neurology, Graduate School of Medical Sciences; Kumamoto University; Kumamoto Japan

3. Department of clinical investigation (biostatistics), Graduate School of Medical Sciences; Kumamoto University; Kumamoto Japan

4. Asian Neurological Intractable Diseases Research and Clinic (AIDReC), Graduate School of Medical Sciences; Kumamoto University; Kumamoto Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201847645/fullpdf

Reference8 articles.

1. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

3. Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibody

4. Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes

5. The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: A potential therapeutic opportunity for atherosclerotic thrombosis

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors;Basic Research in Cardiology;2024-07-17

2. New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis;Bleeding, Thrombosis and Vascular Biology;2024-05-16

3. Immune checkpoint inhibitor-associated cardiovascular toxicities: A review;Heliyon;2024-03

4. Interaction between NSCLC Cells, CD8+ T-Cells and Immune Checkpoint Inhibitors Potentiates Coagulation and Promotes Metabolic Remodeling—New Cues on CAT-VTE;Cells;2024-02-07

5. Detection and evaluation of signals for immune-related adverse events: a nationwide, population-based study;Frontiers in Oncology;2024-01-26